Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Telecoms

Powerlist 2012: Soren Carlsen, Novo Ventures

Carlsen is on the board of PTC Therapeutics and Santaris Pharma, and was previously a board member of 7TM Pharma and Arpida.


Nov 23, 2012

Powerlist 2012: Michael Blaustein, DuPont Ventures

Blausteinwas director of the University Intellectual Property Programme at DuPont from 2004 to 2008. He previously worked at DuPont in research and development portfolio management from 2000 to 2004 and as a business director for non-wovens in Europe from 1997 to 1999.

Nov 23, 2012

Powerlist 2012: Sakae Asanuma, Astellas

Asanuma was previously a director at Yasuda Enterprise Development America, a venture firm backed by Japan-based insurers Sompo Japan Insurance and Meiji Yasuda Life Insurance.

Nov 23, 2012

The Big Deal: Intractable Intarcia

With such sizeable funding in place, if Intarcia can carry out a successful trial it would be in a stronger position to reap the returns of what could be a blockbuster treatment worth billions of dollars per year as well as a technology potentially applicable in other areas.

Nov 18, 2012

Powerlist paints portrait of industry

Our forthcoming Powerlist covering the 100 most powerful people in corporate venturing is due for publication on November 26 and makes for a fascinating insight into who are the key decision-makers in this growing industry.

Nov 18, 2012

2012 Powerlist: Mark Read, WPP Digital

Read say: "Digital is now something like 30% of revenue [at WPP] and Paidcontent ranked us number seven in its list of the top global digital media businesses. What we are trying to do is digitise the group."

Nov 13, 2012
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here